References
Black DAK, Pole JD. Priorities for medical research: indices of burden. British Journal of Social and Preventative Medicine 29: 222–227, 1975
Blau N, Drummond MF. Migraine. Office of Health Economics, London, 1991
Commonwealth of Australia. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Department of Health, Housing and Community Services, Woden, A.C.T., 1990
Davies LM, Drummond MF. The economic burden of schizophrenia. Psychiatric Bulletin 14: 522–525, 1990
Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. British Journal of Urology, in press, 1992
Evans RG. We have seen the future and they is us: health care and the greying of Canada. Discussion Paper no. 84-92, Department of Economics, University of British Columbia, Vancouver, 1984
Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: a comparative analysis. American Journal of Public Health 70: 1249–1260, 1980
Henry D. Economic analysis as an aid to subsidisation: the development of Australian guidelines for Pharmaceuticals. PharmacoEconomics 1: 54–67, 1992
Jones-Lee MW. The value of life: an economic analysis. Martin Robertson, London, 1976
Koopmanschap MA, Van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Social Science and Medicine 34: 1005–1010, 1992
Ontario Ministry of Health. Guidelines for preparation of economic analysis to be included in submission to drug programs branch for listing in the Ontario drug benefit formulary/comparative drug index. Toronto, Ministry of Health, 1991
Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labour costs of migraine headache in the US. PharmacoEconomics 2: 67–76, 1992
Rice DP. Estimating the cost of illness. Health Economics Series No. 6, Public Health Service, US Government Printing Office, Washington, DC, 1966
STG. The impact of AIDS guidelines. The Hague, STG, (Steering Group on Health Technology), 1989
Scitovsky AA, Rice DP. Estimates of the direct and indirect costs of Acquired Immunodeficiency Syndrome in the US 1985, 1986 and 1991. Public Health Reports 102: 5–17, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drummond, M. Cost-of-Illness Studies. Pharmacoeconomics 2, 1–4 (1992). https://doi.org/10.2165/00019053-199202010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199202010-00001